P16346 AF NFT

Bowman-Birk type wound-induced trypsin inhibitor

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibdw4fxobyjasn3dyaaagcwrrjkmdt25vhe6q3yqvddh7gmusn5uy/metadata.json
IPFS of structure file: 
bafybeihd6coukfedgye4zgxnokh2ln3oefmvhxrw2hbjfy4beyxsixl7ym/AF-P16346-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7b996410Da79507A3D80841daE0455C84DAf7E51
First NFT owner address (bech32): 
genesis10wvkgyx609g850vqssw6upz4epx67lj3eh845m
Current NFT ID #183057 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
183057
Accession (UniProt):
P16346
Name::
Bowman-Birk type wound-induced trypsin inhibitor
Experimental Method:
Predicted structure
Sequence source:
MEDICAGO SATIVA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P16346 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P16346|IBBWT_MEDSA Bowman-Birk type wound-induced trypsin inhibitor OS=Medicago sativa OX=3879 PE=1 SV=1 TTACCNFCPCTRSIPPQCRCTDIGETCHSACKTCLCTKSIPPQCHCADITNFCYPKCN